Structures of a hemoglobin-based blood substitute: insights into the function of allosteric proteins  by Kroeger, Kenneth S & Kundrot, Craig E
Structures of a hemoglobin-based blood substitute: insights into
the function of allosteric proteins
Kenneth S Kroeger and Craig E Kundrot*
Background: Potential blood substitutes can be based on hemoglobin. Two
problems must be overcome with acellular hemoglobin-based blood substitutes,
however: the oxygen affinity of purified human hemoglobin is too high for it to
deliver oxygen to tissues, and hemoglobin tetramers dissociate into ab dimers
that can cause kidney damage. A modified form of hemoglobin, rHb1.1, has
reduced oxygen affinity as the result of an Asnb108→Lys mutation, and
dimerization is prevented by the insertion of a glycine residue between the
sequences of the normal a chains to produce one covalently continuous di-a-
chain. Determination of the structure of rHb1.1 would provide structure-based
explanations for the altered properties of rHb1.1.
Results: We determined the structures of the deoxy form of rHb1.1 at 2.0 Å
resolution and of cyanomet-rHb1.1 at 2.6 Å resolution. Deoxy-rHb1.1 adopts the
classic ‘T state’ quaternary structure, but cyanomet-rHb1.1 adopts a novel
quaternary structure, the B state. The most striking feature of the tertiary
structures is a charged hydrogen bond involving Lysb108 that is broken in the
T→B state transition. The glycine bridge within the di-a-chain is well defined in
both structures and appears to cause adoption of the B state instead of the
previously observed ligand-bound quaternary structures R or Y/R2.
Conclusions: A charged hydrogen bond between Lysb108 and Tyrb35 is
broken in the transition between the deoxy and ligand-bound forms of rHb1.1.
This structural change reduces the oxygen affinity of rHb1.1 by changing the
relative stability of deoxy and ligand-bound states. Furthermore, our observations
highlight the importance of small conformational changes in allosteric proteins,
even in their most rigid domains. Three ligand-bound quaternary structures of
hemoglobin (R, Y/R2 and B) have now been described. In contrast, only one
quaternary structure has been observed for deoxyhemoglobin (T). The structural
degeneracy of the high oxygen affinity form of hemoglobin is an important
reminder that allosteric proteins may have multiple quaternary structures that are
functionally very similar. This degeneracy of quaternary structures has important
implications for the regulation of allosteric proteins, because different quaternary
structures may be stabilized by different allosteric effectors.
Introduction 
Several problems associated with transfusions of human
donor blood have motivated the development of blood sub-
stitutes [1,2]. The two main strategies that have been used
so far for developing blood substitutes have been based 
on perfluorocarbons and hemoglobin [3]. There are two
major problems associated with acellular hemoglobin-based
blood substitutes: firstly, in the absence of 2,3-bisphospho-
glycerate (BPG), which is normally present in the red blood
cells, the oxygen affinity of hemoglobin is too high for it 
to deliver oxygen to tissues [4]; secondly, the hemoglobin
tetramers dissociate into ab dimers that can cause kidney
damage [5,6]. These problems have been overcome by
engineering a modified from of human hemoglobin Ao
(HbAo) called rHb1.1 [7].
The rHb1.1 molecule provides a potential acellular, hemo-
globin-based blood substitute, and it contains four changes
relative to HbAo [7]. There are two mutations that over-
come the primary problems of acellular hemoglobin-based
blood substitutes: the Asnb108→Lys mutation that occurs
in the variant hemoglobin Presbyterian [8] was introduced
into rHb1.1, and this mutation lowers the oxygen affinity
into the physiologically useful range (Fig. 1); the second
mutation prevents dissociation by replacing the two
a chains with one covalent polypeptide chain that has the
sequence (a chain 1)–Gly–(a chain 2), thereby creating 
a single di-a-chain. The added glycine is referred to as
‘the glycine bridge’. The result of these mutations is a
molecule that has an oxygen-binding curve very similar to
that of whole blood [7]. Two other modifications are also
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present in rHb1.1 because, for large scale manufacturing,
it is overexpressed in E. coli: the final protein product 
contains methionine instead of valine at the N terminus of
both the a and the b chains. Phase II clinical trials have
been carried out for rHb1.1 in which patients received
dosages up to 100g [9].
Structural information is needed to explain three aspects
of the functional properties of rHb1.1. Firstly, it is not
understood how the Presbyterian mutation (Asnb108→
Lys) has such a large effect on the oxygen affinity. In addi-
tion to being located far from the heme moieties, residue
b108 is located in the a1b1 interface, which changes very
little between the deoxy-‘T’ quaternary structure [10] and
the ligand-bound (oxy or carbonmonoxy) quaternary struc-
tures R [11], Y [12] or R2 [13]. Indeed, this interface is the
region used to superimpose structures when comparing
quaternary structures [12–14]. Secondly, an explanation is
required for how the insertion of the glycine bridge and
the formation of the di-a-chain (with the concomitant
removal of one a chain N terminus and one a chain C ter-
minus) has such a small impact on the Bohr effect (Fig. 1).
Thirdly, an understanding of how the Val1→Met mod-
ifications on the a and b chains lower the magnitude of
the Bohr effect (Fig. 1) may be provided by structural
information.
We determined the structure of deoxy-rHb1.1 and
cyanomet-rHb1.1 (cyanide replaces oxygen as a ligand 
and ‘met’ refers to the heme iron in the ferric oxidation
state (+3) instead of the normal ferrous (+2) oxidation
state) and used the symmetry model of Monod, Wyman
and Changeux (MWC) [15] to answer these questions. A
new interaction formed as a result of the Presbyterian
mutation is functionally equivalent to the action of BPG
binding in red blood cells (i.e. it stabilizes the non-ligand-
bound deoxy structure relative to ligand-bound struc-
tures). Modification and removal of the N termini appear
to have stabilizing effects on the protonated form of
rHb1.1 that lower the magnitude of Bohr effect. Surpris-
ingly, the ligated form of rHb1.1 adopts a novel quaternary
structure, in support of the idea that allosteric proteins
may adopt different quaternary structures that have the
same biological activity.
Results
Structure solutions and refinement
Deoxy-rHb1.1 crystallized isomorphously with deoxy HbAo
grown in high salt conditions, and diffraction data were 
collected to 2.0Å resolution. One ‘tetramer’ (i.e. the di-a-
chain plus the two b chains) occupies the asymmetric unit.
The R value of the refined model containing 373 water
molecules and alternate sidechain conformations for five
residues is 16.4% (Rfree =23.2%).
Cyanomet rHb1.1 was prepared using K3Fe(CN)6 and
KCN [16] and crystallized from polyethylene glycol
(PEG) in space group P212121 with unit cell parame-
ters a=102.54Å, b=115.17Å and c =56.70Å. This is a 
new crystal form of hemoglobin, which also contains one
‘tetramer’ in the asymmetric unit. Diffraction data were
collected to 2.6Å resolution. The R value for the final
model containing 84 solvent sites in addition to fitting all
protein atoms is 17.5% (Rfree =27.8%).
Quaternary structure
Previous crystallographic studies have revealed three 
quaternary structures for hemoglobin. Deoxyhemoglobin
adopts the T-state quaternary structure when crystallized
from high salt [10] or from PEG [17]. Several ligand-bound
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Figure 1
Schematic illustration of changes in the
functional properties of HbAo and rHb variants.
Using the nomenclature rHbn.m, where n=1
the Asnb108→Lys mutation is present, and
m=1 indicates the presence of the di-a-chain.
All rHb variants have N-terminal methionine
residues in the a and b chains instead of the
valine found in HbAo. P50 is the partial pressure
of oxygen at which 50% of the hemes have
oxygen bound. The Bohr coefficient describes
how the oxygen affinity changes with pH; it is
the slope of a plot of log10(P50) against pH. At
pH>6, the Bohr coefficient is a negative
number, so an increase in the Bohr coefficient
corresponds to a decrease in the magnitude of
the Bohr effect. The overall changes on going
from HbAo to rHb1.1 are: ∆P50 =+12.7 torr
and ∆Bohr=+0.15. The data in this figure are
from reference [7]; they were obtained at 25°C
in 50mM HEPES (pH7.4) and 100mM NaCl.
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forms of hemoglobin (i.e. oxyhemoglobin [11], carbon-
monoxyhemoglobin [18] and methemoglobin [19]) crys-
tallize in the R state when grown from high salt concen-
trations. Another closely related quaternary structure of
ligand-bound hemoglobin, known as Y [12,20] or R2 [13],
was discovered relatively recently. The structures are very
similar except for the orientation of the C-terminal dipep-
tides of the a and b chains and can, therefore, be regarded
as one quaternary structure with two variations in tertiary
structure. We refer to this quaternary structure as Y/R2; it
has been proposed that this third quaternary structure is
an intermediate between T and R [12,13], or an end state
in the progression T→R→Y/R2 [21,22]. 
Whereas deoxy-rHb1.1 adopts the classic T-state quater-
nary structure, cyanomet-rHb1.1 adopts a novel quaternary
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Figure 2
The T→B transition. (a) The global stereoview
of the T→B transition is shown, with a2b2
dimers shown schematically as ‘ball-and-stick’
dumbbells: T (blue), R (red), R2 (gold) and B
(green). The hemoglobin tetramers were
oriented by superimposing the a1b1 of the
ligand-bound hemoglobins upon the a1b1
dimer of deoxyhemoglobin (blue). The large
spheres indicate the position of the center of
mass of each subunit and the small sphere
indicates the center of mass of each dimer.
The rotation axes for the quaternary structure
transitions are indicated by red (T→R), gold
(T→R2), and green (T→B) lines (coordinates
given in Table 2). The axes for the T→R and
T→R2 transitions are approximately
perpendicular to the page, whereas the axis
for the T→B transition is approximately
parallel to the plane of the page. The
coordinates used for the structures were
obtained from PDB files pdb2hhb.ent (T),
pdb1hho.ent (R), pdb1bbb.ent (R2), and the
final refined model of cyanomet-rHb1.1.
(b) Backbone stereoview of quaternary
transitions. The Ca backbones of the ligated
a2b2 dimers (R, red; R2, gold; and B, green)
are shown superimposed on the deoxy a2b2
T dimer (blue) in the same orientation as in (a).
The locations of the switch region (small
circle), flexible joint region (box) and G helix of
the a2 subunit (large circle) are indicated. The
different effects of the quaternary transitions is
most noticeable for the G helix of the a2
subunit and for the ribbon at the perimeter of
the molecule. 
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structure, the B state (named for ‘blood substitute’ and
‘glycine bridge’). The root mean square deviation (rmsd)
between Ca of the deoxy-rHb1.1 ‘tetramer’ and the
T-state deoxy-HbAo is 0.30–0.40Å. The B state rHb1.1,
however, superimposes on T, R, Y and R2 state HbAo
structures with rmsd=1.54–4.26Å. The T→B transition is
markedly different from the T→R and T→Y/R2 transi-
tions (Fig. 2; Table 1). The T→B transition is a 9.6° rota-
tion and 0.32Å translation along a screw axis that is
oriented 89° or more from the axes that describe the other
transitions. Moreover, in a geometric sense, the B state
does not lie on a path between any other states.
The B state is achieved by new packing arrangements in
the classical ‘switch’ and ‘flexible joint’ regions. These
regions were originally identified on the basis of the T→R
transition [14]. The switch region is so named because
Hisb297 packs between Proa144 and Thra141 in T, and
between Thra141 and Thra138 in R — that is, it effec-
tively jumps a turn of the a1C helix in the T→R transition
(Fig. 3a). In the T→B transition, the ‘a1b1 dimer’ (i.e.
a1–a141, b11–b1146) rotates with respect to the ‘a2b2
dimer’ (i.e. a143–a283, b21–b2146) about a pivot point
located near this classical switch region. So, the switch
region behaves as a pivot point rather than as a switch in
the T→B transition. Packing contacts between the a1FG
corner (residues a189–a195) and the b2C helix (residues
b235–b241) involve the same sidechains in both T and R,
which is why they were originally described as the flexible
joint [14]. In the T→R or T→Y/R2 transitions, Trpb237
can be thought of as a ball within a socket containing
Aspa194. In T→B, however, the ball-and-socket joint
becomes dislocated as Aspa94 pulls away from Trpb237
during the transition (Fig. 3b). 
We used a modified difference distance matrix (DDM)
analysis [23,24] to confirm that no other regions in the
B-state structure underwent large changes relative to
deoxy-rHb1.1 (T). Residues were flagged if they con-
tained atoms that were between 2.4 and 3.5Å from an
atom in another residue in the T or B state and if the
interatomic distance changed by more than 0.1Å in the
T→B transition. The advantage of this method is that 
it does not require structures to be superimposed. The
largest shifts identified by this method involved b108
(described below) or residues breaking interactions in 
the flexible joint region: Trpb237–Aspa194, Glub243–
Arga192, Argb240–Leua191 and Valb234–Arga1141 inter-
actions. The DDM analysis confirmed that the site of the
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Table 1
Quaternary structure transformations.
Transition T→R T→R2 T→Y T→B
Axis direction cosines (0.937, 0.032, 0.348) (0.638,0.035,0.770) (0.723,0.004,0.690) (0.365,0.075,–0.928)
Point on axis (1.85, –13.36, 0.00) (1.22, –9.63, 0.00) (1.23, –9.92, 0.00) (–0.88, 16.26, 0.00)
Rotation angle (°) –13.2 –23.0 –21.4 –9.6
Translation (Å) 1.36 2.92 2.85 0.32
Figure 3
The T→B transition. (a) The switch region. B (green), R (red), and R2
(orange) were superimposed on T (blue) using all Ca atoms of the
a1b1 dimers (lower ribbon). (b) The flexible joint region. Structures are
superimposed and colored as in (a), and functionally important
residues are labeled.
b108 Presbyterian mutation and the flexible joint region
undergo the largest shifts in the T→B transition.
The B state contains subunit interfaces that are more 
like those of T than those of the other ligand-bound
states. Solvent-accessible surface area calculations show
that B has significantly less area buried in interfaces than
the other quaternary structures (Table 2). The size of the
a1b1, a1a2 and b1b2 interfaces are much closer to those of
the T state than of the ligand-bound states. The a1b2
interface buried surface area is closer to those of the
ligand-bound states, lying between these values and those
of the T states.
Tertiary structure
The most striking feature of the deoxy-rHb1.1 structure 
is the charged hydrogen bond formed between Lysb108
Nz and Tyrb35 Oh (Fig. 4a). This interaction is present 
in both b chains: the distances between these atoms in 
the two different b chains of rHb1.1 are 3.08 Å and 3.25Å.
This bond is broken, however, in the B state. In the B
state, the Lysb108 occupies well defined density and has
below average temperature factors. The B state Lysb108,
however, does not interact with Tyrb35 (Fig. 4b); the
Lysb108 Nz–Tyrb35 Oh distances are 5.32 and 3.58Å.
Instead, the Lysb108 points into the central solvent cavity
and interacts with solvent rather than protein functional
groups. Thus, the hydrogen bond between Lysb108 and
Tyrb35 is broken in the T→B transition and is not
replaced with a compensatory intraprotein interaction.
The other major mutation in rHb1.1, the glycine bridge, 
is well defined by electron density in both the T- and
B-state structures (Fig. 5). In terms of a normal HbAo
tetramer in the crystallographic asymmetric unit, there are
two places where the glycine bridge of rHb1.1 could be
inserted: between the N terminus of a1 and the C termi-
nus of a2 or between the N terminus of a2 and the C ter-
minus of a1. Thus, in a crystal structure, the glycine
bridge could be observed at half occupancy at both of
these positions in the molecule. In both of our structures,
however, the glycine bridge is clearly localized to just one
of the two possible positions. The other possible position
for the glycine bridge lacks significant electron density.
The unique positioning of the glycine bridge contrasts
with an earlier difference Fourier analysis at 2.5Å [7],
which suggested that the glycine bridge was present in the
deoxy-rHb1.1 crystal structure with approximately equal
occupancies of both positions. The reason for the different
occupancies of the glycine bridge is not known.
The glycine bridge is accommodated in T with little dis-
tortion relative to T-state HbAo, but rearrangements occur
in B (Fig. 6). The rmsd between mainchain atoms of a141
and a143 in deoxy-rHb1.1 and the corresponding residues
in T-state HbAo (a1141 and a21) is 0.70–0.77Å. The rmsd
between these residues in the B state and the R, Y or R2
states, however, is 1.4–2.2Å. The (f,ψ) values of the
glycine bridge (81°, –171°) in T are energetically accessible
to glycine but not other residues. Therefore, other residues
would not be able to preserve the T-state structure.
The N-terminal Val→Met substitutions in the a and
b chains introduce stabilizing van der Waals interactions 
in rHb1.1 without introducing distortions. The Meta1
sidechain interacts with the mainchain and sidechain
atoms of Lysa127 and Sera131; the Metb1 sidechain inter-
acts with the mainchain and sidechain atoms of Valb133,
the sidechain of Leub81, and the mainchain atoms of
Leub78 and Lysb132. These interactions are not present
in HbAo, but they do not distort the T structure; the rmsds
between the N-terminal mainchain atoms of the a and
b chains of rHb1.1 and HbAo are 0.66 and 1.13Å, respec-
tively. These interactions, involving the N-terminal Met
residue, are similar to the interactions seen in a mutant 
of HbAo containing the Valb1→Met substitution [25].
The heme-site structures in deoxy-rHb1.1 and deoxy-
HbAo are very similar (Fig. 7). The rmsds of a and b heme
atoms between deoxy-rHb1.1 and deoxy-HbAo grown in
high salt conditions are 0.32 and 0.19Å, respectively.
These values are essentially the same as the rmsd between
Ca atoms of deoxy rHb1.1 and deoxy HbAo grown in high
salt conditions (0.30Å).
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Table 2
Buried interfacial surface areas.
Interfacial Area (Å2)
Cyanomet Deoxy-rHb1.1
Interface rHb1.1 (B) (T) T R R2 Y
Total Interface 6633 7202 7113 7447 7380 7210
a1a2 533 666 639 874 914 842
b1b2 7 0 0 530 368 463
a1b1 1828 1814 1774 1912 1902 1864
a1b2 1218 1454 1463 1110 1147 1089
The Lee and Richards method [57] implemented in X-PLOR was used to calculate the surface areas in Å2. The water probe radius was 1.4 Å.
The heme-site structure of the cyanomet rHb1.1, however,
is roughly equally similar to T, R, Y and R2 heme-site
structures. Superimposition of residues lining the heme-
binding pocket produces rmsds of 0.55 to 0.64 Å for
a hemes and 0.79 to 0.98Å for b hemes (Fig. 7). The heme
sites in B are not identical to hemes sites in any other qua-
ternary state, although it is clear that the hemes are ligated
and flat (as in R, R2 and Y). In the cyanomet hemes, the
average Fe–C–N bond angles are 155° for the a hemes and
140° for the b hemes (i.e. in the middle of the 102°–177°
range seen in other cyanomet structures [26–33]). The con-
formation of residues next to the hemes resemble R more
than T, although there is substantial variation.
Discussion
Quaternary structures
The rHb1.1 molecule is probably forced into the B state
by the glycine bridge (a142). The distances between the
carboxyl oxygens of the C termini (a1141 O) and the
amino nitrogens of the N termini (a21 N) of the R , R2 ,
and Y structures are 3.30Å, 11.15Å, and 5.65Å, respec-
tively. One glycine residue cannot span the distance
required in the R2 or Y states, and the bond angles and
torsion angles that would be required in a bridging glycine
in R would be severely strained. Thus, the glycine bridge
in rHb1.1 could not bridge the gap in the R, R2 or Y 
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Figure 4
The b108 region. (a) Section of the electron-density map for deoxy-
rHb1.1 showing the charged hydrogen bond between residues
Lysb108 and Tyrb35. The map is contoured at 1.25s using
coefficients (2Fo–Fc) and phases from the final model. Deoxy-rHb1.1 is
colored by atom type (yellow; carbon, red; oxygen and blue; nitrogen).
(b) Section of the electron-density map for cyanomet-rHb1.1 showing
that the charged hydrogen bond between residues Lysb108 and
Tyrb35 in T is broken. The map is contoured at 1.3s using coefficients
(2Fo–Fc) and phases from the final model. 
Figure 5
The glycine-bridge region. (a) Section of the deoxy-rHb1.1 electron-
density map showing the glycine-bridge region of the di-a-chain.
(b) Section of the cyanomet-rHb1.1 electron-density map showing the
glycine bridge region of the di-a-chain. Residues Arga141, Glya142,
and Vala143 are shown. The maps are contoured at 0.75s using
coefficients (2Fo–Fc) and phases from the final models. The atoms are
colored by atom type (yellow, carbon; red, oxygen; blue, nitrogen). 
conformations without a change in tertiary or quater-
nary structure. Although simple ‘cut and paste’ modeling
would have been sufficient to predict the structure of the
glycine bridge in deoxy-rHb1.1, methods allowing changes
in tertiary and/or quaternary structure would have been
required for modeling the conformation of the glycine
bridge in the ligand-bound states.
The observation of three different quaternary structures for
ligand-bound hemoglobin [11–13] supports the notion that
one functional form of an allosteric protein may have more
than one quaternary structure. The ligand-bound states 
of hemoglobin (R, Y/R2, B) have high oxygen affinity,
similar to the oxygen affinity of individual a or b subunits
[34,35]. This suggests that the intersubunit interactions in
the ligand-bound quaternary structures do not significantly
alter oxygen affinity. In contrast, the low affinity deoxyhe-
moglobin form has only been observed in one quaternary
structure, T [10,17], suggesting that a precise set of inter-
subunit interactions is required for the low affinity form 
to be produced. If other allosteric proteins also have multi-
ple quaternary structures for the same functional form (e.g.
low catalytic activity), it would greatly increase the possi-
bilities for regulating biological activity, since each quater-
nary structure could be stabilized by different allosteric
effectors.
Tertiary structure
Several models describe the link between hemoglobin
structure and its oxygen-binding properties [15,36–43].
Several of these are reviewed in the context of recent
experimental data and a general formulation [44]. Because
we have determined the structure of rHb1.1 under two
limiting conditions (no ligand-bound and fully ligand-
bound) and do not have structural data on partially ligand-
bound species, the simplest model to adopt for the
discussion is the well known MWC model [15]. The
classic two-state version of this model contains three vari-
ables: L is the allosteric equilibrium constant between no
ligand-bound T and R, such that L =[To]/[Ro], and KT and
KR are the dissociation constants for oxygen binding to T
and R, respectively. Because it seems that rHb1.1 cannot
form the R or Y/R2 quaternary structures, rHb1.1 can be
considered to be a two-state system (T and B), as a first
approximation. Thus, the oxygen-binding properties of
rHb1.1 are a function of KT(rHb1.1), KB(rHb1.1), and
L(rHb1.1). 
Oxygen affinities (KT and KB)
Structural and functional data for rHb1.1 suggest that the
oxygen dissociation constants are not changed dramati-
cally from those of HbAo. The structures of the deoxy-
rHb1.1 and deoxy-HbAo heme sites are extremely similar
(rmsd ≤ 0.3 Å), as is the tertiary structure of the entire 
molecule (rmsd ≤ 0.3 Å). This suggests that KT(rHb1.1) ≈
KT(HbAo). The implications of the B-state heme struc-
tures are less clear. Although the structure of the B-state
heme sites is most like the structure of the other ligand-
bound heme sites (rmsd = 0.55–0.96 Å, between B and 
the ligated states, compared with 0.62–0.98 Å between 
B and T states), the degree of similarity is less than 
that observed for the T-state structure. Oxygen-binding
curves of rHb1.1 interpreted in terms of the two-state
MWC model confirm that the oxygen affinity of the 
T and ‘R’ states change very little (AJ Mathews, per-
sonal communication). Thus, it appears that the simplest 
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Figure 6
Comparison of structures in the glycine-bridge region. (a) Deoxy-rHb1.1
is colored by atom type (green, carbon; red, oxygen; blue, nitrogen) and
deoxy-HbAo grown from high salt [10] and PEG [17] solutions are
colored cyan except for the yellow atoms that correspond to a carboxyl
oxygen and the peptide nitrogens of a141 and a1, respectively. The
mainchain atoms of residues a1141 and a21 of HbAo and a141 and
a143 of rHb1.1 were used to perform the superimposition. (b) As (a),
except that the ligand-bound structures illustrating R [11], Y [12,20]
and R2 [13] are colored purple. (c) The glycine-bridge region shown
after superimposing the Ca atoms of the entire a1b1 dimer (to the right
in the figure): T rHb1.1 is blue; B, green; R, red; R2, orange. The
glycine bridges of rHb1.1 (a142) are colored grey. 
structural interpretation is in agreement with binding
data: the rHb1.1 oxygen dissociation constants are rela-
tively unchanged.
Allosteric equilibrium (L)
The interaction between Lysb108 Nz and Tyrb35 Oh
provides an explanation for the reduced oxygen affinity 
of rHb1.1. The Asnb108→Lys mutation has a greater
effect on P50 than any other mutation in rHb1.1 (Fig. 1).
Despite the fact that the b108 mutation occurs in the rela-
tively rigid a1b1 interface [14], there are structural changes
in this interface which are important for the function of
the Asnb108→Lys mutation. The interaction between
Lysb108 and Tyrb35 is facilitated in the T state by a
deformation within the G-helix (residues b99–b117) that,
compared to the other T-state structures, rotates Lysb108
10° toward Tyrb35 (Fig. 8). In HbAo, the whole G helix
rotates 5.1–7.0° in the opposite direction when the quater-
nary structure changes from T to R, Y or R2 (i.e. the b108
sidechain rotates a total of 15–17° between T-state rHb1.1
and the HbAo ligand-bound structures; see Fig. 8). This
latter rotation causes Asnb108 Cb and Tyrb35 Oh to
move apart by 0.8–1.3Å. Model building shows that a
Lysb108 could not hydrogen bond to Tyrb35 in the R, Y
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Figure 7
Heme sites. The heme site of the B state
(green) compared to that of the T (blue) and 
R (red) states of Hb. The a heme
superimposition was performed using all
atoms of residues a43 (distal Phe), a58
(distal His), a62 (distal Val), a87 (proximal
His) and the a heme. The b heme
superimposition was performed using all
atoms of residues b42 (distal Phe), b63
(distal His), b67 (distal Val), b92 (proximal
His) and the b heme. The atoms used for the
superimpositions and the mainchain of the
F helix and FG corner are shown. The distal
residues are those above the heme (center),
and the proximal histidine is below the heme
in this view.
Figure 8
Comparison of structures in the b108–b35
region. Deoxy-rHb1.1 (yellow), deoxy-HbAo
grown from high salt [10] and PEG [17]
solutions (blue), and ligand-bound structures
illustrating R [11], Y [12, 20], and R2 [13]
structures (purple) are shown. The mainchain
atoms of the G helix (residues b99–b117)
were used to calculate the superimposition.
This view shows that the hydrogen-bond
interaction between Lysb108 and Tyrb35 is
broken in B (green) and that b108, in context
of the G helix, adopts a conformation similar to
the T structures. This superimposition shows
how the rotation of the G helix affects the
distance between Lysb108 Nz in rHb1.1 and
Tyrb35 Oh in other structures; it increases
from 3.08 Å in deoxy-rHb1.1 to 3.35–3.44Å in
other T structures and to 3.78–4.06Å in the
ligand-bound structures. This view also shows
that b108 in deoxy-rHb1.1 is rotated within
the context of the G helix compared to other
deoxyhemoglobin structures.
or R2 states and could interact with the internal solvent
cavity instead. As expected, Lysb108 in the B state inter-
acts with the internal solvent cavity.
The effect of this broken interaction, then, is to destabilize
the ligand-bound state(s) of rHb1.1 relative to the deoxy
state. In terms of the two-state MWC model, this corre-
sponds to an increase in the allosteric equilibrium constant
L(rHb1.1) [15]. An increased value of L(rHb1.1) produces
an increased P50 (i.e. lower oxygen affinity, as observed in
Fig. 1). Oxygen-binding measurements interpreted with
the two-state model confirm this result; the change in P50
is primarily due to an increase in L(rHb1.1) (AJ Mathews,
personal communication). This stabilization of T relative
to the ligand-bound states is analogous to BPG binding 
to and subsequent stabilization of the deoxy state. Thus,
one may think of the Presbyterian mutation as being the
intramolecular functional equivalent of BPG binding.
The rHb1.1 T- and B-state structures provide evidence
against previous speculation that the Asnb108→Lys muta-
tion reduces oxygen affinity by destabilizing the ligand-
bound state, by disrupting interactions made by Asnb108
and/or Hisa103 [8]. Early crystallographic [45] and NMR
[46] studies proposed that Hisa103 makes a hydrogen
bond to Asnb108. Later high resolution crystal structures,
however, show that this interaction has a poor geometry
(e.g. the distance between hydrogen bond donor and
acceptor is 3.7 Å) and show that Asnb108 and Hisa103
interact with the central solvent cavity. Thus, there are 
no direct interactions with Asnb108 in the ligand-bound 
or nonbound state(s) to disrupt with the Presbyterian
mutation. Furthermore, Hisa103 interacts with the same
residues in T and B state rHb1.1 and in HbAo (i.e. its 
conformation is not affected by the mutation). Contrary to
the early prediction, then, the Asnb108→Lys mutation
appears to stabilize the T state (by hydrogen bonding 
to Tyrb35) rather than destabilizing the ligand-bound
state(s).
The effect of the glycine bridge on L(rHb1.1) and P50
is small (Fig. 1). On the basis of the crystal structures
alone, it would appear that the glycine bridge stabilizes 
T relative to the ligand-bound states since little distortion
of the a chains is required to accommodate the additional
residue in T. The P50 values, however, show that the
glycine bridge actually stabilizes the ligand-bound states
slightly (rHb0.0→rHb0.1, rHb1.0→rHb1.1; Fig. 1). The
source of this destabilization of the deoxy state or stabi-
lization of the ligand-bound states is not obvious. It is dif-
ficult to estimate the energetic cost of rearranging the R, Y
or R2 termini to accommodate the glycine bridge because,
as termini, relatively few interactions determine their con-
formation. Whether the glycine bridge primarily desta-
bilizes the deoxy state or stabilizes the ligand-bound state
is not clear.
Bohr effect
The N terminal methionines and the glycine bridge
decrease the magnitude of the Bohr effect in rHb1.1 by
stabilizing the ‘protonated’ conformation of the T state
(i.e. the conformation seen in the deoxy structure). The
methionines reduce the Bohr effect by 0.20 units (HbAo→
rHb0.0, Fig. 1), presumably because of the additional van
der Waals interactions made by the methionine sidechain.
Since there is no change in the Bohr effect of HbAo with
only the Valb1→Met mutation [47], the reduction of the
Bohr effect in HbAo→rHb0.0 appears to be due to the
Vala1→Met mutations. One a chain N-terminal methion-
ine can be replaced by the glycine bridge without affect-
ing the Bohr coefficient by more than 0.03 units (rHb0.0→
rHb0.1 and rHb1.0→rHb1.1; Fig. 1). Thus, it appears that
the glycine bridge and the N-terminal methionine are
approximately equally effective in stabilizing the proto-
nated T-state conformation. Perutz and Imai [48] sug-
gested a similar stabilization of T based on the inter-
action of hydrophobic sidechains at position b2 with the
hydrophobic interior of the b chains. The structure of
deoxy-rHb1.1 at other sites implicated in the Bohr effect
(Hisb2, Hisb146, Glub43 and Hisa122 [10,46,49,50]) is
unchanged.
Biological implications
The oxygen affinity of purified human hemoglobin is too
high for it to deliver oxygen to tissues, and hemoglobin
tetramers dissociate into ab dimers that may cause
kidney damage. Both of these problems must be over-
come before it will be possible to use hemoglobin-based
blood substitutes. In a modified hemoglobin rHb1.1, an
Asnb108→Lys mutation reduces its oxygen affinity, and
dimerization is prevented through the insertion of a
glycine between a chains to form a covalent di-a-chain.
Determination of the structure of rHb1.1 provides struc-
ture-based explanations for its altered properties. 
The deoxy- and cyanomet rHb1.1 structures show why
rHb1.1 has reduced oxygen affinity and a reduced Bohr
effect. The reduced oxygen affinity of rHb1.1 is due to a
change in the relative stability of the deoxy and ligand-
bound structural states. A charged hydrogen bond
between Lysb108 and Tyrb35 is broken in the transition
between deoxy- and ligand-bound forms of rHb1.1. 
This stabilizing interaction in the deoxy state occurs in
the relatively rigid a1b1 interface, which is generally
regarded as functionally unimportant. The rHb1.1 struc-
tures show that even small structural changes can have
dramatic effects on the functional properties of an
allosteric protein. The N-terminal methionines and the
glycine bridge appear to stabilize the protonated deoxy
conformation and thereby reduce the Bohr effect. 
Surprisingly, the ligand-bound form of rHb1.1 has a ter-
tiary structure similar to that of the other ligand-bound
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states, but it adopts a new quaternary structure. The
existence of three ligand-bound quaternary structures
(R, Y/R2, and now B) of hemoglobin is evidence that 
a protein may achieve the same functional properties 
in different quaternary structures. The possibilities for
regulating the protein’s biological activities, would be
greatly increased by this apparent redundancy, because
each quaternary structure could be stabilized by dif-
ferent allosteric effectors.
Materials and methods
Deoxy-rHb1.1 structure determination
We obtained rHb1.1 from Somatogen, Inc. and crystallized using con-
ditions very similar to the high salt conditions used to crystallize deoxy-
HbAo [10]. The crystals are isomorphous to deoxy-HbAo crystals grown
in high salt conditions [10]. Diffraction data were collected on a
Siemens X100 area detector using the Midwest Area Detector Inter-
face developed at Argonne National Laboratory. Data were reduced
with XDS and XSCALE [51–53]. The data set was 93.1% complete in
the resolution range 82.0–2.0 Å with Rsym = 4.6% (Table 3). 
An initial model was constructed from deoxy-HbAo [10] by replacing
residues a1, b1 and b108 with alanine. The glycine bridge was not
included in the model. The model was refined using X-PLOR [54] and
O [55]. The glycine bridge was inserted, residues a1 and b1 were
changed from Ala to Met and residue b108 was changed from Ala to
Lys only after 2Fo–Fc and difference Fourier maps indicated clear posi-
tions for these extra atoms. Statistics describing the final model are
given in Table 4.
Cyanomet-rHb1.1 structure determination
The cyanomet derivative of rHb1.1 was prepared using a twofold molar
excess (heme concentration) of K3Fe(CN)6 and KCN [16]. Crystals
were obtained from hanging drops containing 15 mg ml–1 cyanomet
rHb1.1, 6.5% PEG 3350, 75 mM ammonium acetate, pH 5.0 and
0.25 mM KCN suspended over a residue containing 13% PEG 3350,
150 mM ammonium acetate, pH 5.0 and 10 mM KCN. The hanging
drops were set up at room temperature and then incubated at 10°C.
The crystals were mounted at 4°C and diffraction data were collected
at 4°C with a Siemens X100 area detector using the Midwest Area
Detector Interface. The crystals belonged to space group P212121 with
unit cell parameters a = 102.54 Å, b = 115.17 Å and c = 56.70 Å. Data
were reduced to intensities with XDS and merged using XSCALE
[51–53]. The data set was 92% complete to 2.6 Å and had Rmerge =
0.056 (Table 3).
The initial model of cyanomet rHb1.1 was obtained by molecular
replacement using the program AMoRe [56]. No solutions were
obtained when using T, R, Y, or R2 Hb tetramers as the molecular
probe. We did, however, find a solution using the T state rHb1.1 ab
‘dimer’ (i.e. a1–a141 and b1–b146) as the probe. After rigid body
refinement using two independent copies of the ab dimer probe, the
R value was 37.7%. 
All refinement calculations were performed with X-PLOR, v.3.1 [54].
The initial model, which did not include the glycine bridge (a142), was
subjected to rigid body refinement followed by simulated annealing;
restrained, individual atom temperature factor refinement; and bulk
solvent masking. An iterative procedure of modifying the model using
the molecular graphics program O [55] followed by Powell minimiza-
tion and restrained, individual atom temperature factor refinement was
repeated until Rfree was unchanged and no more solvent sites were
evident. The bridging glycine was inserted only after 2Fo–Fc and differ-
ence Fourier maps indicated clear positions for these atoms. Statistics
describing the final model are given in Table 4.
Accession numbers
The coordinates have been deposited in the Protein Data Bank with
PDB codes: deoxy-rHb1.1, 1abw; cyanomet-rHb1.1, 1aby. 
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Table 3
Data collection statistics: data collection parameters.
Deoxy-rHb1.1 Cyanomet-rHb1.1
Unit cell dimensions
a (Å) 62.90 102.54
b (Å) 81.98 115.17
c (Å) 53.92 56.70
b (°) 98.99
Space group P21 P212121
Contents of 
asymmetric unit di-a-chain + b1 + b2 di-a-chain + b1 + b2
Resolution range (Å) 82.0–2.0 115.2–2.6
Number of crystals used 5 1
Number of observations 70 840 55 634
Number of unique 
observations 34 054 19 521
Completeness of data (%)
I/s > 0.0 
All data 93.1 91.5
High resolution shell (Å) 88.8 (2.2–2.0) 69.5 (2.8–2.6)
I/s > 2.0
All data 77.1 68.8
High resolution shell 56.1 (2.2–2.0) 29.2 (2.8–2.6)
Rmerge (%)* 4.6 5.6
*Rmerge = Σ | (Ihkl – I< hkl >)| / Σ(I< hkl >), where I< hkl > is the mean intensity
of all reflections equivalent to reflection hkl by symmetry.
Table 4
Refinement statistics: final refinement parameters.
Deoxy-rHb1.1 Cyanomet-rHb1.1
Resolution range (Å) 5.0–2.0 10.0–2.6
Number of protein atoms 4645 4572
Number of solvent atoms 373 84
Number of residues with alternate 
sidechain conformations 5 0
Signal/noise cutoff (F/s) 2.0 2.0
R factor (%)* 16.4 17.5
Free R factor (%)† 23.2 27.8
Rms deviations from ideal geometry
Bond lengths (Å) 0.014 0.009
Bond angles (°) 1.66 1.37
Dihedral angles (°) 20.5 20.6
Improper angles (°) 2.09 1.24
Mean temperature factors (Å2)
Mainchain 15.3 33.0
Sidechain 17.4 35.3
Solvent 39.9 39.2
*R factor = Σ | Fo–Fc | / Σ Fo. †10% of reflections were used for Rfree.
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